Aizawa Hospital (Location: Matsumoto City, Nagano Prefecture, Director: Takao Aizawa, hereinafter referred to as "Aizawa Hospital"), a Social Medical Corporation Jisenkai, announces the completion of its trial implementation of the generative AI solution for medical institutions "Ubie Generative AI" provided by Ubie Inc. (Headquarters: Chuo-ku, Tokyo, Co-CEOs: Yoshinori Abe, Kota Kubo, hereinafter referred to as "Ubie") and the commencement of its official adoption across the entire hospital. In conjunction with this, Aizawa Hospital will introduce the mobile app version (iOS compatible) of "Ubie Generative AI" provided by Ubie. By leveraging voice recognition and text generation functions on business iPhones, an environment will be established where generative AI can be utilized anywhere, regardless of ward or outpatient setting, further accelerating the reduction of cognitive load for medical professionals and the standardization of work quality. ■ Background of Official Adoption Aizawa Hospital began the trial implementation of "Ubie Generative AI," the first in the Koshinetsu area, in September 2024 (*). Approximately 80 individuals, including doctors, nurses, and staff from the International Affairs Department supporting foreign patients, participated in testing text generation, summarization, and voice recognition functions. As a result, it was confirmed that the mobile version's voice recognition and text generation functions, utilizing business iPhones, demonstrated high effectiveness in various medical settings. Based on the proven contribution to reducing cognitive load and standardizing work quality across diverse departments, the decision was made to officially adopt "Ubie Generative AI" and its mobile app version throughout the hospital. The 2026 fiscal year medical fee revision policy indicates further strengthening of evaluation for "Medical DX and Data Utilization." Aizawa Hospital established a DX Promotion Office early on and has strategically adva